Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Ensemble Learning Framework with GLCM Texture Extraction for Early Detection of Lung Cancer on CT Images
59
Zitationen
6
Autoren
2022
Jahr
Abstract
Lung cancer has emerged as a major cause of death among all demographics worldwide, largely caused by a proliferation of smoking habits. However, early detection and diagnosis of lung cancer through technological improvements can save the lives of millions of individuals affected globally. Computerized tomography (CT) scan imaging is a proven and popular technique in the medical field, but diagnosing cancer with only CT scans is a difficult task even for doctors and experts. This is why computer-assisted diagnosis has revolutionized disease diagnosis, especially cancer detection. This study looks at 20 CT scan images of lungs. In a preprocessing step, we chose the best filter to be applied to medical CT images between median, Gaussian, 2D convolution, and mean. From there, it was established that the median filter is the most appropriate. Next, we improved image contrast by applying adaptive histogram equalization. Finally, the preprocessed image with better quality is subjected to two optimization algorithms, fuzzy c-means and k-means clustering. The performance of these algorithms was then compared. Fuzzy c-means showed the highest accuracy of 98%. The feature was extracted using Gray Level Cooccurrence Matrix (GLCM). In classification, a comparison between three algorithms-bagging, gradient boosting, and ensemble (SVM, MLPNN, DT, logistic regression, and KNN)-was performed. Gradient boosting performed the best among these three, having an accuracy of 90.9%.
Ähnliche Arbeiten
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 · 15.803 Zit.
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 · 11.471 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.872 Zit.
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 · 9.989 Zit.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
2015 · 9.415 Zit.